Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the control of obesity. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://joanmplb553775.blogoscience.com/45575239/retaglutide-a-promising-glp-1-receptor-agonist